Lv6
2010 积分 2025-03-26 加入
Hyaluronidase activity in serum of patients with monoclonal gammapathy
10天前
已完结
Toxicologic Pathology Forum*: Opinion on Qualitative Severity Descriptors to Express Magnitude of Changes in Clinical Pathology Endpoints in Nonclinical Toxicity Studies
26天前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
1个月前
已完结
Toxicologic Pathology Forum*: Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist’s Dilemma
2个月前
已关闭
Subcutaneous delivery of monoclonal antibodies: How do we get there?
2个月前
已完结
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
3个月前
已完结
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
3个月前
已完结
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
3个月前
已完结
Application of Empirical Scalars To Enable Early Prediction of Human Hepatic Clearance Using In Vitro-In Vivo Extrapolation in Drug Discovery: An Evaluation of 173 Drugs
4个月前
已完结
Factor XIa–specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis
4个月前
已完结
皖公网安备34019202002308
